trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Goldenhar Syndrome D006053 1 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Supratentorial Neoplasms D015173 1 associated lipids
Myopathy, Central Core D020512 1 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Rubinstein-Taybi Syndrome D012415 1 associated lipids
Adenomyosis D062788 1 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Tavakoli-Yaraki M et al. Induction of apoptosis by Trichostatin A in human breast cancer cell lines: involvement of 15-Lox-1. 2013 Tumour Biol. pmid:23055198
Yang Q et al. Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: role of histone acetylation. 2012 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:23043075
Luo Y et al. High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy. 2013 Eur. J. Cancer pmid:23040637
Park KS et al. Histone modification-mediated Lhx2 gene expression. 2012 Biochem. Biophys. Res. Commun. pmid:23036195
Banik D et al. Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity. 2012 PLoS ONE pmid:23028998
Zhao ZN et al. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC. 2012 PLoS ONE pmid:23028803
Merschbaecher K et al. Acetylation-mediated suppression of transcription-independent memory: bidirectional modulation of memory by acetylation. 2012 PLoS ONE pmid:23028801
Zhang L et al. Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts. 2012 J. Biol. Chem. pmid:23024362
Hoque MA et al. Cyclic tetrapeptides with thioacetate tails or intramolecular disulfide bridge as potent inhibitors of histone deacetylases. 2012 Bioorg. Med. Chem. Lett. pmid:23021104
Jin H et al. HDAC inhibitor trichostatin A promotes proliferation and odontoblast differentiation of human dental pulp stem cells. 2013 Tissue Eng Part A pmid:23013422
Chang X et al. DNA methylation of NDRG2 in gastric cancer and its clinical significance. 2013 Dig. Dis. Sci. pmid:23010743
Vaidya AS et al. Novel histone deacetylase 8 ligands without a zinc chelating group: exploring an 'upside-down' binding pose. 2012 Bioorg. Med. Chem. Lett. pmid:23010266
Bergman JA et al. Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth. 2012 J. Med. Chem. pmid:23009203
Guo SW et al. Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis. 2013 Fertil. Steril. pmid:22999795
Shi YL et al. Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in mice. 2012 J. Dermatol. Sci. pmid:22999682
Zhang QC et al. Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib in A549 cell line. 2012 Asian Pac. J. Cancer Prev. pmid:22994780
Ma J et al. Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in esophageal cancer. 2012 Int. J. Mol. Med. pmid:22992863
Wang HF et al. Transcription levels of sirtuin family in neural stem cells and brain tissues of adult mice. 2012 Cell. Mol. Biol. (Noisy-le-grand) pmid:22992439
Tsuboi H et al. Epigenetic memory of DNAi associated with cytosine methylation and histone modification in fern. 2012 Plant Signal Behav pmid:22990449
Darlyuk-Saadon I et al. The bZIP repressor proteins, c-Jun dimerization protein 2 and activating transcription factor 3, recruit multiple HDAC members to the ATF3 promoter. 2012 Nov-Dec Biochim. Biophys. Acta pmid:22989952
Otsuji TG et al. Dynamic link between histone H3 acetylation and an increase in the functional characteristics of human ESC/iPSC-derived cardiomyocytes. 2012 PLoS ONE pmid:22984602
de Souza CF et al. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis. 2012 PLoS ONE pmid:22984562
Zhang S et al. [Effect of trichostatin A and paclitaxel on the growth and apoptosis of lung adenocarcinoma cell lines]. 2012 Zhonghua Zhong Liu Za Zhi pmid:22967465
Mateen S et al. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells. 2012 Epigenetics pmid:22965008
Brown RE et al. Superinduction of leptin mRNA in mouse hypothalamic neurons. 2012 Neuroreport pmid:22964970
Liu N et al. Histone deacetylase inhibitors inducing human cervical cancer cell apoptosis by decreasing DNA-methyltransferase 3B. 2012 Chin. Med. J. pmid:22964322
Miyagawa K et al. Possible involvement of histone acetylation in the development of emotional resistance to stress stimuli in mice. 2012 Behav. Brain Res. pmid:22963996
Tomosugi M et al. Retinoblastoma gene-independent G1 phase arrest by flavone, phosphatidylinositol 3-kinase inhibitor, and histone deacetylase inhibitor. 2012 Cancer Sci. pmid:22957647
Sadoul K et al. HDAC6 controls the kinetics of platelet activation. 2012 Blood pmid:22955928
Shan J et al. ATF4-dependent regulation of the JMJD3 gene during amino acid deprivation can be rescued in Atf4-deficient cells by inhibition of deacetylation. 2012 J. Biol. Chem. pmid:22955275
Tigges J et al. Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expression. 2013 J. Invest. Dermatol. pmid:22951721
Liao V et al. Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects. 2012 Bioorg. Med. Chem. Lett. pmid:22932316
To SQ et al. Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer. 2012 J. Steroid Biochem. Mol. Biol. pmid:22929011
Conway GD et al. Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation. 2012 Glia pmid:22927334
Zhang C et al. Decreased PADI4 mRNA association with global hypomethylation in hepatocellular carcinoma during HBV exposure. 2013 Cell Biochem. Biophys. pmid:22907585
Joosten M et al. Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype. 2013 Haematologica pmid:22899583
Karolczak-Bayatti M et al. Expression of the GTP-binding protein Gαs in human myometrial cells is regulated by ubiquitination and protein degradation: involvement of proteasomal inhibition by trichostatin A. 2012 Reprod Sci pmid:22875848
Hu X et al. Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner. 2013 Stem Cells Dev. pmid:22873791
Yu J et al. Regulation of radiosensitivity by HDAC inhibitor trichostatin A in the human cervical carcinoma cell line Hela. 2012 Eur. J. Gynaecol. Oncol. pmid:22873101
Serrat N et al. Deacetylation of C/EBPβ is required for IL-4-induced arginase-1 expression in murine macrophages. 2012 Eur. J. Immunol. pmid:22865229
Colussi C et al. P300/CBP associated factor regulates nitroglycerin-dependent arterial relaxation by N(ε)-lysine acetylation of contractile proteins. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:22859492
Balaguer TM et al. Dual regulation of P-glycoprotein expression by trichostatin A in cancer cell lines. 2012 BMC Mol. Biol. pmid:22846052
Shao G et al. [Effect of monoamine oxidase inhibitor on the differentiation of malignant glioma cell]. 2012 Sheng Wu Yi Xue Gong Cheng Xue Za Zhi pmid:22826952
Qiao F et al. Enforced expression of RASAL1 suppresses cell proliferation and the transformation ability of gastric cancer cells. 2012 Oncol. Rep. pmid:22825043
Kraus J Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes. 2012 Ann. N. Y. Acad. Sci. pmid:22823387
Lin KT et al. HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy. 2012 Clin. Cancer Res. pmid:22811583
Vadnal J et al. Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer's disease. 2012 Exp Brain Res pmid:22811216
Mostovich LA et al. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer. 2012 Epigenetics pmid:22805760
Cheng DD et al. Antitumor activity of histone deacetylase inhibitor trichostatin A in osteosarcoma cells. 2012 Asian Pac. J. Cancer Prev. pmid:22799338
Agudelo M et al. Alcohol-induced serotonergic modulation: the role of histone deacetylases. 2012 Alcohol pmid:22796363
Sung TY et al. Innovative in vitro chemo-hormonal drug therapy for refractory thyroid carcinomas. 2012 J. Korean Med. Sci. pmid:22787366
Oh HJ et al. Trichostatin a improves preimplantation development of bovine cloned embryos and alters expression of epigenetic and pluripotency genes in cloned blastocysts. 2012 J. Vet. Med. Sci. pmid:22785124
Yao J et al. ERK inhibition enhances TSA-induced gastric cancer cell apoptosis via NF-κB-dependent and Notch-independent mechanism. 2012 Life Sci. pmid:22781708
Zheng L et al. [Detecting acetylated proteins by affinity chromatography column]. 2012 Zhonghua Xue Ye Xue Za Zhi pmid:22781610
Guo X et al. Histone deacetylase inhibitors promote mice corneal allograft survival through alteration of CD4+ effector T cells and induction of Foxp3+ regulatory T cells. 2012 May-Jun Cell. Immunol. pmid:22776176
Tong K et al. Schizosaccharomyces pombe Hat1 (Kat1) is associated with Mis16 and is required for telomeric silencing. 2012 Eukaryotic Cell pmid:22771823
Cogdill AP et al. Targeting the MAGE A3 antigen in pancreatic cancer. 2012 Surgery pmid:22770803
Feng L et al. Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells. 2013 J. Mol. Med. pmid:22763818
Gan L et al. Histone deacetylases regulate gonadotropin-releasing hormone I gene expression via modulating Otx2-driven transcriptional activity. 2012 PLoS ONE pmid:22761896
Jasek E et al. Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells. 2012 Anticancer Res. pmid:22753739
Brose RD et al. Activation of the stress proteome as a mechanism for small molecule therapeutics. 2012 Hum. Mol. Genet. pmid:22752410
Liu S et al. Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells. 2013 Ann. Surg. Oncol. pmid:22752337
Soleymani Fard S et al. Prostaglandin E2 induces growth inhibition, apoptosis and differentiation in T and B cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6). 2012 Prostaglandins Leukot. Essent. Fatty Acids pmid:22749740
Scholl C et al. Distinct and overlapping gene regulatory networks in BMP- and HDAC-controlled cell fate determination in the embryonic forebrain. 2012 BMC Genomics pmid:22748179
Zou Y et al. Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia. 2012 J Hematol Oncol pmid:22747680
Chen H et al. LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma. 2012 Cancer Lett. pmid:22743615
Balmer NV et al. Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. 2012 Hum. Mol. Genet. pmid:22723015
He Q et al. Characterization of an apical ceramide-enriched compartment regulating ciliogenesis. 2012 Mol. Biol. Cell pmid:22718902
Kan R et al. Potential role for PADI-mediated histone citrullination in preimplantation development. 2012 BMC Dev. Biol. pmid:22712504
Itoh M et al. Trichostatin A enhances glutamate transporter GLT-1 mRNA levels in C6 glioma cells via neurosteroid-mediated cell differentiation. 2013 J. Mol. Neurosci. pmid:22711563
Zhang YW et al. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation. 2012 PLoS ONE pmid:22701735
Nunes MJ et al. Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1/2-Sp3-dependent pathway. 2012 J. Lipid Res. pmid:22693257
Jung N et al. Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma. 2012 J. Korean Med. Sci. pmid:22690089
Royce SG et al. Effects of the histone deacetylase inhibitor, trichostatin A, in a chronic allergic airways disease model in mice. 2012 Arch. Immunol. Ther. Exp. (Warsz.) pmid:22684086
Kim Y et al. Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein. 2012 J. Biol. Chem. pmid:22679019
Mitchell MD et al. Epigenetic regulation of cytokine production in human amnion and villous placenta. 2012 Mediators Inflamm. pmid:22665947
Glait-Santar C et al. Expression pattern of SVEP1 alternatively-spliced forms. 2012 Gene pmid:22659106
Orlova DY et al. Arrangement of nuclear structures is not transmitted through mitosis but is identical in sister cells. 2012 J. Cell. Biochem. pmid:22644811
Buurman R et al. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. 2012 Gastroenterology pmid:22641068
Kim YS et al. Histone deacetylase is required for the activation of Wnt/β-catenin signaling crucial for heart valve formation in zebrafish embryos. 2012 Biochem. Biophys. Res. Commun. pmid:22634317
Wu TC et al. Genistein enhances the effect of trichostatin A on inhibition of A549 cell growth by increasing expression of TNF receptor-1. 2012 Toxicol. Appl. Pharmacol. pmid:22626855
Viñuelas J et al. Towards experimental manipulation of stochasticity in gene expression. 2012 Prog. Biophys. Mol. Biol. pmid:22609563
Dhawan D et al. DNMT1: an emerging target in the treatment of invasive urinary bladder cancer. 2013 Urol. Oncol. pmid:22609058
Hsu DW et al. Dynamic acetylation of lysine-4-trimethylated histone H3 and H3 variant biology in a simple multicellular eukaryote. 2012 Nucleic Acids Res. pmid:22600736
Truong M et al. Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence. 2012 Br. J. Cancer pmid:22596233
Park J et al. ARD1 binding to RIP1 mediates doxorubicin-induced NF-κB activation. 2012 Biochem. Biophys. Res. Commun. pmid:22580278
Srirattana K et al. Full-term development of gaur-bovine interspecies somatic cell nuclear transfer embryos: effect of trichostatin A treatment. 2012 Cell Reprogram pmid:22578161
Hizume K et al. Nano-scale analyses of the chromatin decompaction induced by histone acetylation. 2010 Arch. Histol. Cytol. pmid:22572182
Bobkov DE et al. [Isolation of tropomyosin particles from the cytosol of cultured cells and their protein composition analysis]. 2012 Tsitologiia pmid:22567898
Yu L et al. Trichostatin A ameliorates myocardial ischemia/reperfusion injury through inhibition of endoplasmic reticulum stress-induced apoptosis. 2012 Arch. Med. Res. pmid:22564421
Catalano MG et al. Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells. 2012 J. Clin. Endocrinol. Metab. pmid:22563106
He M and Guo Q [Cerebral protection of Trichostatin A preconditioning in rats with middle cerebral artery occlusion and the relationship between Trichostatin A and IL-1β]. 2012 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:22561570
Cheng SP et al. Regulation of leptin receptor expression in human papillary thyroid cancer cells. 2012 Biomed. Pharmacother. pmid:22560341
Hou W et al. Hypoxia-induced deacetylation is required for tetraploid differentiation in response to testicular ischemia-reperfusion (IR) injury. 2012 Nov-Dec J. Androl. pmid:22556385
Hsieh TH et al. Phthalates stimulate the epithelial to mesenchymal transition through an HDAC6-dependent mechanism in human breast epithelial stem cells. 2012 Toxicol. Sci. pmid:22552774
Meng J et al. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways. 2012 Oncol. Rep. pmid:22552631
Kang FW et al. Effects of trichostatin A on HIF-1α and VEGF expression in human tongue squamous cell carcinoma cells in vitro. 2012 Oncol. Rep. pmid:22552321
Reddy P Editorial: HDAC inhibition begets more MDSCs. 2012 J. Leukoc. Biol. pmid:22547132
Chawalit S et al. Trichostatin A and ascorbic acid assist in the development of porcine handmade cloned embryos via different physiologic pathways. 2012 Reprod Sci pmid:22534331
Li Q and Chen H Silencing of Wnt5a during colon cancer metastasis involves histone modifications. 2012 Epigenetics pmid:22522911